Author

D. J. Glass

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Physiology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

T. Shavlakadze· 2 shared A. Boyapati· 1 shared C. A. Kyratsous· 1 shared C. E. Zimmerli· 1 shared D. J. Ham· 1 shared F. Oliveri· 1 shared G. A. Joseph· 1 shared G. Kimble· 1 shared

Activity by Year

2019-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

T. Shavlakadze

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Dual roles of mTORC1-dependent activation of the ubiquitin-proteasome system in muscle proteostasis

M. S. Kaiser, G. Milan, S. Lin, F. Oliveri, K. Chojnowska, L. A. Tintignac, N. Mittal, C. E. Zimmerli, D. J. Glass, M. Zavolan, D. J. Ham, M. A. Ruegg

The paper reveals that mTORC1 promotes muscle atrophy by enhancing the ubiquitin-proteasome system through dual mechanisms, while also showing that proteome integrity depends on ubiquitination.

bioRxiv · Nov 16, 2021Physiology

Activin A correlates with the worst outcomes in COVID-19 patients, and can be induced by cytokines via the IKK/NF-kappa B pathway

M. McAleavy, Q. Zhang, J. Xu, L. Pan, M. Wakai, P. J. Ehmann, M. F. Wipperman, T. Shavlakadze, S. C. Hamon, A. Boyapati, L. G. Morton, C. A. Kyratsous, D. J. Glass

The paper shows elevated Activin A and FLRG levels in COVID-19 patients predict severe outcomes like mechanical ventilation and mortality.

bioRxiv · Feb 4, 2021 · PreprintImmunology

Inhibition of mTORC1 signaling in aged rats counteracts the decline in muscle mass and reverses multiple parameters of muscle signaling associated with sarcopenia

G. A. Joseph, S. Wang, W. Zhou, G. Kimble, H. Tse, J. K. Eash, T. Shavlakadze, D. J. Glass

This study shows that inhibiting mTORC1 signaling in aged rats increases muscle mass and reverses sarcopenia-related gene expression changes.

bioRxiv · Mar 28, 2019Physiology